PASCALE ADAM 4
4 · HEMISPHERX BIOPHARMA INC · Filed Jan 30, 2019
Insider Transaction Report
Form 4
Pascale Adam
Chief Accounting Officer
Transactions
- Award
Options to buy Common Stock
2019-01-28+142,046→ 142,046 totalExercise: $0.22From: 2019-01-28Exp: 2029-01-28→ Common Stock (142,046 underlying)
Footnotes (1)
- [F1]This option is being issued to senior management for a voluntary 50% deferral in salary.